What Is the Influence of HIV Serostatus on HbA1c? A Prospective Analysis Using Continuous Glucose Monitoring
Diabetes Care · 2024
DOI: 10.2337/dc24-0225 ↗Kurz gefasst
Fachartikel in der Zeitschrift Diabetes Care, 2024. Verfasst von Harriet Daultrey und 4 weiteren Autor:innen. Beteiligte Einrichtung: Brighton and Sussex Medical School, Brighton, East Sussex, U.K. Hauptthemen laut MEDLINE: Glycated Hemoglobin, Blood Glucose, HIV Infections. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 40 Literaturangaben. Gefördert von: Dexcom.
Abstract (Originalsprache)
OBJECTIVE Type 2 diabetes (T2D) is reported to be more common in people living with HIV (PLWH). Clinical guidelines recommend screening for diabetes in PLWH, but there is no agreed method due to studies reporting HbA1c is falsely low in PLWH. These studies were performed in the early HIV era when participants were taking older preparations of antiretroviral therapy that are rarely used today. We aimed to investigate whether HIV serostatus influences HbA1c. RESEARCH DESIGNS AND METHODS We conducted a prospective cohort study of PLWH and age- and sex-matched HIV-negative participants who were purposely recruited from clinics in Brighton, U.K. Each participant wore a Dexcom G6 continuous glucose monitor (CGM) for up to 10 days, had glucose measured during an oral glucose tolerance test, and fructosamine and paired HbA1c were measured. We performed regression analysis to assess the influence of HIV on HbA1c and used a separate model for CGM glucose, venous glucose, and fructosamine. In addition, we included predictor variables used in previous studies that explored HbA1c discrepancy. RESULTS We recruited 60 PLWH (90% men, 50% with T2D, mean ± SD age 57 ± 10.7 years, 100% undetectable viral load) and 48 people without HIV (92% men, 30% with T2D, mean age 57.7 ± 8.9 years). We found that HIV serostatus did not have a significant influence on HbA1c within the regression models. CONCLUSIONS We performed a comprehensive assessment of glycemia to assess whether HIV serostatus influences HbA1c. We did not find any strong evidence that HIV serostatus influenced HbA1c. The results of our study support incorporating HbA1c into routine clinical blood work in PLWH.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Brighton and Sussex Medical School, Brighton, East Sussex, U.K.
- Division of Diabetes, Endocrinology and Metabolism, Imperial College London, London, U.K.
- University of Surrey, Guildford, Surrey, U.K.
ORCID-Profile: Harriet Daultrey, Nick S Oliver, Ali Jason Chakera
Förderung
- Dexcom
Zitieren
APA
Daultrey, H., Oliver, N. S., Wright, J., Levett, T. J., & Chakera, A. J. (2024). What Is the Influence of HIV Serostatus on HbA1c? A Prospective Analysis Using Continuous Glucose Monitoring. Diabetes Care. https://doi.org/10.2337/dc24-0225
Vancouver
Daultrey H, Oliver NS, Wright J, Levett TJ, Chakera AJ. What Is the Influence of HIV Serostatus on HbA1c? A Prospective Analysis Using Continuous Glucose Monitoring. Diabetes Care. 2024. doi:10.2337/dc24-0225
BibTeX
@article{Daultrey2024,
author = {Daultrey, Harriet and Oliver, Nick S and Wright, Juliet and Levett, Tom J and Chakera, Ali Jason},
title = {What Is the Influence of HIV Serostatus on HbA1c? A Prospective Analysis Using Continuous Glucose Monitoring},
journal = {Diabetes Care},
year = {2024},
doi = {10.2337/dc24-0225}
}
EUVIMED